BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 10982823)

  • 1. Induction of postmitotic neuroretina cell proliferation by distinct Ras downstream signaling pathways.
    Peyssonnaux C; Provot S; Felder-Schmittbuhl MP; Calothy G; Eychène A
    Mol Cell Biol; 2000 Oct; 20(19):7068-79. PubMed ID: 10982823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of gene induction and cell growth by the Ras effector Rlf.
    Wolthuis RM; de Ruiter ND; Cool RH; Bos JL
    EMBO J; 1997 Nov; 16(22):6748-61. PubMed ID: 9362489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ral-specific guanine nucleotide exchange factor activity opposes other Ras effectors in PC12 cells by inhibiting neurite outgrowth.
    Goi T; Rusanescu G; Urano T; Feig LA
    Mol Cell Biol; 1999 Mar; 19(3):1731-41. PubMed ID: 10022860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The P34G mutation reduces the transforming activity of K-Ras and N-Ras in NIH 3T3 cells but not of H-Ras.
    Oliva JL; Zarich N; Martínez N; Jorge R; Castrillo A; Azañedo M; García-Vargas S; Gutiérrez-Eisman S; Juarranz A; Boscá L; Gutkind JS; Rojas JM
    J Biol Chem; 2004 Aug; 279(32):33480-91. PubMed ID: 15181015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signals from the Ras, Rac, and Rho GTPases converge on the Pak protein kinase in Rat-1 fibroblasts.
    Tang Y; Yu J; Field J
    Mol Cell Biol; 1999 Mar; 19(3):1881-91. PubMed ID: 10022875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Raf-1 mutant that dissociates MEK/extracellular signal-regulated kinase activation from malignant transformation and differentiation but not proliferation.
    Dhillon AS; Meikle S; Peyssonnaux C; Grindlay J; Kaiser C; Steen H; Shaw PE; Mischak H; Eychène A; Kolch W
    Mol Cell Biol; 2003 Mar; 23(6):1983-93. PubMed ID: 12612072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation.
    Khosravi-Far R; White MA; Westwick JK; Solski PA; Chrzanowska-Wodnicka M; Van Aelst L; Wigler MH; Der CJ
    Mol Cell Biol; 1996 Jul; 16(7):3923-33. PubMed ID: 8668210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the Ral and phosphatidylinositol 3' kinase signaling pathways by the ras-related protein TC21.
    Rosário M; Paterson HF; Marshall CJ
    Mol Cell Biol; 2001 Jun; 21(11):3750-62. PubMed ID: 11340168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of phospholipase D by Ras proteins mediated by its effectors Ral-GDS, PI3K and Raf-1.
    Lucas L; Penalva V; Ramírez de Molina A; Del Peso L; Lacal JC
    Int J Oncol; 2002 Sep; 21(3):477-85. PubMed ID: 12168089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential roles of Akt, Rac, and Ral in R-Ras-mediated cellular transformation, adhesion, and survival.
    Osada M; Tolkacheva T; Li W; Chan TO; Tsichlis PN; Saez R; Kimmelman AC; Chan AM
    Mol Cell Biol; 1999 Sep; 19(9):6333-44. PubMed ID: 10454580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine Ksr interacts with MEK and inhibits Ras-induced transformation.
    Denouel-Galy A; Douville EM; Warne PH; Papin C; Laugier D; Calothy G; Downward J; Eychène A
    Curr Biol; 1998 Jan; 8(1):46-55. PubMed ID: 9427625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple ras effector pathways contribute to G(1) cell cycle progression.
    Gille H; Downward J
    J Biol Chem; 1999 Jul; 274(31):22033-40. PubMed ID: 10419529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct role of phosphatidylinositol 3-kinase and Rho family GTPases in Vav3-induced cell transformation, cell motility, and morphological changes.
    Sachdev P; Zeng L; Wang LH
    J Biol Chem; 2002 May; 277(20):17638-48. PubMed ID: 11884391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ras mediates radioresistance through both phosphatidylinositol 3-kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-independent signaling pathways.
    Grana TM; Rusyn EV; Zhou H; Sartor CI; Cox AD
    Cancer Res; 2002 Jul; 62(14):4142-50. PubMed ID: 12124353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of the TATA-binding protein by Ras cellular signaling.
    Johnson SA; Mandavia N; Wang HD; Johnson DL
    Mol Cell Biol; 2000 Jul; 20(14):5000-9. PubMed ID: 10866657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Function of the Rho family GTPases in Ras-stimulated Raf activation.
    Li W; Chong H; Guan KL
    J Biol Chem; 2001 Sep; 276(37):34728-37. PubMed ID: 11457831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive activation of the MEK/ERK pathway mediates all effects of oncogenic H-ras expression in primary erythroid progenitors.
    Zhang J; Lodish HF
    Blood; 2004 Sep; 104(6):1679-87. PubMed ID: 15166036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling through mitogen-activated protein kinase and Rac/Rho does not duplicate the effects of activated Ras on skeletal myogenesis.
    Ramocki MB; Johnson SE; White MA; Ashendel CL; Konieczny SF; Taparowsky EJ
    Mol Cell Biol; 1997 Jul; 17(7):3547-55. PubMed ID: 9199290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the protein kinase Raf-1 by oncogenic Ras through phosphatidylinositol 3-kinase, Cdc42/Rac and Pak.
    Sun H; King AJ; Diaz HB; Marshall MS
    Curr Biol; 2000 Mar; 10(5):281-4. PubMed ID: 10712905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.